Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 91,407
Prepaid expenses	208,056
Total Current Assets	299,463
Deferred offering costs		89,500
Marketable securities held in Trust Account	230,021,238
TOTAL ASSETS	230,320,701	89,500
LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY
Current liabilities
Accrued expenses	312,942
Advances from related parties	870
Promissory note – related party		69,500
Total Current Liabilities	313,812	69,500
Warrant liabilities	18,505,400
Deferred underwriting commission payable	8,650,000
Total Liabilities	27,469,212	69,500
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, 23,000,000 shares and no shares at redemption value at December 31, 2021 and 2020, respectively	230,021,238
Shareholders’ (Deficit) Equity
Preference shares, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding at December 31, 2021 and 2020
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding, at December 31, 2021 and 2020	575	575
Additional paid-in capital		24,425
Accumulated deficit	(27,170,324)	(5,000)
Total Shareholders’ (Deficit) Equity	(27,169,749)	20,000
TOTAL LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY	$ 230,320,701	$ 89,500